Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1-Seropositive and -Seronegative Adults

The objective of this study was to evaluate and compare both the safety and tolerability and the humoral and cell-mediated immune responses for two influenza virus subunit vaccines, one with MF59 adjuvant (Fluad) and one without an adjuvant (Agrippal), in healthy and in human immunodeficiency virus...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Durando, P., Fenoglio, D., Boschini, A., Ansaldi, F., Icardi, G., Sticchi, L., Renzoni, A., Fabbri, P., Ferrera, A., Parodi, A., Bruzzone, B., Gabutti, G., Podda, A., Del Giudice, G., Fragapane, E., Indiveri, F., Crovari, P., Gasparini, R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2008
Assuntos:
Vaccine Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2238067/
https://ncbi.nlm.nih.gov/pubmed/18003811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00316-07
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados